Clinical Trial

The DENOCHARCOT Trial

Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated August 7, 2024 (before its estimated October 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
The aim of the present trial is to assess the efficacy of treatment of acute Charcot foot in diabetes patients with Prolia® on clinical relevant Outcomes in a randomized, double blind, placebo-controlled trial.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2020-09-07; most recent amendment 2024-08-06.
Status change: Not Yet Recruiting → Recruiting 2021-07-27
Trial Details
NCT Number NCT04547348
Lead Sponsor Ole Lander Svendsen
Conditions Charcot Foot, Diabetes Mellitus
Enrollment 38 participants
Start Date 2020-11-01
Primary Completion 2025-10-01 (estimated)
Study Completion 2026-10-01 (estimated)
Updated on ClinicalTrials.gov 2024-08-07